Resolian Fordham UK LCMS Bioanalytical Lab Tour

Ever wondered what happens to your samples once they reach our laboratory?

Take an exclusive behind-the-scenes look at the complete sample journey through our state-of-the-art Fordham facility in Cambridgeshire, UK.

The Sample Journey Revealed:

📦 Sample Receipt & Management – Secure chain of custody protocols

🔬 Sample Preparation – Expert wet chemistry techniques and processing

⚡ LC-MS/MS Analysis – Cutting-edge separation sciences and mass spectrometry

📊 Data Processing & QC – Rigorous quality control and analytical validation

📈 Results Delivery – Comprehensive reporting and client communication

About Our Fordham Laboratory:

Our purpose-built 440m² analytical sciences facility features dedicated areas for separation sciences and elemental analysis, with access-controlled environments designed to eliminate contamination risks. The lab combines advanced instrumentation with streamlined workflows to deliver precise, reliable results for pharmaceutical and biopharmaceutical clients worldwide.

Specialized Capabilities:

  • High-resolution LC-MS/MS platforms 
  • Small molecule bioanalysis
  • Method development and validation
  • Elemental analysis under controlled conditions
  • GLP-compliant testing environments
  • Expert sample management systems

From the moment your samples arrive at our Fordham facility to the delivery of validated results, witness the meticulous attention to detail and scientific excellence that drives drug development forward.

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.